The directors present the strategic report and financial statements for the year ended 31 December 2025.

The principal activity of the company continued to be that of the operation of care home facilities.

The company's turnover has increased due to an increase in rates charged. The directors consider the results for the period to be satisfactory. The company will continue to seek every opportunity to increase profitable turnover.

The Conway Group was restructed effective 27 August 2025, therefore from this date and at 31 December 2025, Brooklands Healthcare Limited's ultimate parent company is Conway Holdings No. 2 Limited, and its registered office is 58 Moneymore Road, Magherafelt, BT45 6HG. There has been no change to the ownership of the group as a result of the restructuring.

The company's operations expose it to a variety of financial risks that include price risk, credit risk, liquidity risk and interest rate risk. The company has in place a risk management programme that seeks to limit the adverse effects on the financial performance of the company by monitoring levels of debt finance and the related finance costs. Given the size of the company, the directors have assumed responsibility for the monitoring of financial risk management.

In accordance with the requirement to analyse the key risks and uncertainties facing the future development of the company, the following have been identified:

• Price risk

The company is exposed to commodity price risk. However, given the size of the company's operations, the costs of managing exposure to commodity price risk exceed any potential benefits. The directors will keep this policy under review having regard to the company's operations and any change in size or nature.

• Credit risk

The company is exposed to credit risk due to its policy of giving credit to residents. However given the nature of the company's activities, the exposure to credit risk is minimal.

• Liquidity risk

The company has financing facilities in place that are designed to ensure there are sufficient available funds for operations and planned expansions.

• Interest rate cash flow risk

The company has interest bearing liabilities. The company has a policy of monitoring its debt finance to ensure certainty of future interest cash flows. The directors will revisit the appropriateness of this policy should the company's operations change in size or nature.

The directors consider revenue, cash at bank and in hand & net assets to be important financial and operational measures of the company’s performance.

Measure                2025    2024

Revenue                £25.9m    £20.9m

Net assets                £9.3m    £36.0m

Cash at bank and in hand            £11.4m    £5.3m

Management continues to monitor operational indicators relevant to the business.

The directors have acted in a way which they consider, in good faith, to be most likely to promote the success of the company for the benefit of its members as a whole, while having regard to the matters set out in section 172(1) of the Companies Act 2006.

In doing so, the directors have considered the long-term sustainability of the business, including the provision of high-quality care to residents, maintaining safe and well-managed care home facilities, and complying with relevant regulatory requirements. The directors recognise that the company’s success is dependent on its relationships with residents, their families, employees, healthcare professionals, local authorities, regulators and suppliers.

The company seeks to support and retain its employees through appropriate training, supervision and working practices, recognising the importance of staff in delivering consistent standards of care. The directors also consider the needs and wellbeing of residents and aim to maintain open communication with residents, families and other stakeholders.

The directors are mindful of the company’s impact on the wider community and seek to operate responsibly, ethically and in accordance with applicable laws and regulations. Decisions during the year were made with consideration of these stakeholder interests and the long-term success of the company.

On behalf of the board

The directors present their annual report and financial statements for the year ended 31 December 2025.

The results for the year are set out on page 11.

As part of the group restructuring effective 27 August 2025, the company paid dividends in the amount of £45m to its parent company at that time, P J Conway Contractors Limited.

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Research and development activities of the company are related to provision of specialist healthcare facilities and services.

Applications for employment by disabled persons are always fully considered, bearing in mind the aptitudes of the applicant concerned. In the event of members of staff becoming disabled, every effort is made to ensure that their employment within the company continues and that the appropriate training is arranged. It is the policy of the company that the training, career development and promotion of disabled persons should, as far as possible, be identical to that of other employees.

The company's policy is to consult and discuss with employees, through unions, staff councils and at meetings, matters likely to affect employees' interests.

Information about matters of concern to employees is given through information bulletins and reports which seek to achieve a common awareness on the part of all employees of the financial and economic factors affecting the company's performance.

The auditors, Moore (N.I.) LLP, are deemed to be reappointed under section 487(2) of the Companies Act 2006.

This is the company’s first year of reporting energy use and associated greenhouse gas emissions under the Streamlined Energy and Carbon Reporting requirements. The company operates care home facilities and recognises the importance of monitoring energy consumption and managing its environmental impact.

The disclosures below set out the company’s energy usage and associated carbon emissions for the reporting period, together with the methodology applied in preparing the information. As this is the first year of reporting, no prior year comparative information has been presented. The company intends to use this information as a basis for monitoring future performance and identifying opportunities to improve energy efficiency across its operations.

GHG Emissions TC02e

* tC02e represents Tonnes Carbon Dioxide Equivalent.

* We have accounted for at least Scopes 1, 2 & 3 mandatory reporting.

* Estimations of data were within the 0 – 10% banding for information included within the above table.

* Outside of Scopes information as per guidance and transparency purposes account for 0.44tCO2e.

* Scopes 2 & 3 includes data that is optional for reporting on under SECR compliance as per GHG protocol guidance.

We have quantified and reported our organisational greenhouse gas (GHG) emissions according to the (GHG) Reporting Protocol.

Energy use data has been collated and converted into Carbon Dioxide equivalent (CO2e) using the most up to date (March 2019) HM Government Environmental Reporting guidelines along with along with the 2025 UK Government Conversion Factors for Company Reporting (DESNZ).

We have used reliable and obtainable data typical of our operations throughout where applicable.

We have chosen to use the operational boundary approach.

Please note that Scope 3 emissions data do not account for all of Scope 3. Mandatory Scope requirements have been met in addition to the inclusion of some voluntary information for transparency reporting purposes.

Total energy use scope 1 & 2

Sustainability approach

Brooklands Healthcare Limited is committed to promoting sustainability. The promotion of a broader sustainability agenda is integral to our professional activities and the management of the organisation. We realise the need to manage environmental matters across all of our operations to ensure future sustainability. We work closely with government agencies and local authorise in our commitment to:

• Prevent and reduce environmental impact in the areas of waste, water, energy and air quality.

• In the procurement of goods and services we seek to ensure our supply chain has responsible social and environmental practice which take sustainability into consideration.

• Seek to fully comply with environmental regulations and adopt best practice wherever practicable

• Identify and pursue opportunities to minimise the environmental impact of our operations, in relation to improving energy efficiency, cost effective and efficient procurement, use of renewable resource.

• Minimising the impact of travel by encouraging staff to use public transport and making available the use of telephone and video conference facilities.

Low carbon projects/environmental action taken

The following carbon saving initiatives have been implemented during the current financial year:

• Purchasing substantial amount of energy from an energy company which seeks to obtain generation of power from renewable source. This includes significant generation from companies which are commonly owned, that generate substantial power from wind turbines and also have plans to grow renewable generation potential via solar projects.

• Microsoft teams meetings encouraged where possible to minimise travel.

• Rental properties for staff located within walking distance of facilities to encourage more walking and reduce usage of motor vehicles.

• Construction team collaborating with inhouse operation & maintenance teams to improve energy and machine efficiency at all of our sites. - Compliance with waste regulation and recycling promotion throughout company operations.

• LED light fitting and occupancy sensor installed in offices. Energy usage monitored monthly. Standby modes enabled for office equipment

• Energy saving design implemented in the refurbishment of our head office and other sites.

• Continued investment in environmental/sustainability training to upskill employees.

Targets

Brooklands Healthcare Limited have engaged in developing both short and long-term targets for energy

consumption and emissions. The following areas will be considered jointly:

• Solicit cost proposals for the optimal deployment of additional roof mounted solar panels and other options for generating energy via use of solar power.

• Market research is being undertaken to determine the most cost effective, non-intrusive and portable energy metering with a view to introducing effective monitoring and targeting of energy consumption.

• Reduce up to 75% of all emissions by 2043.

• Achieve in line with EU & UK target set of Net Zero by 2050.

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:

• select suitable accounting policies and then apply them consistently;

• make judgements and accounting estimates that are reasonable and prudent;

• state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

• prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

We have audited the financial statements of Brooklands Healthcare Limited (the 'company') for the year ended 31 December 2025 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

• give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its profit for the year then ended;

• have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

• have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

• the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

• the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

• adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

• the financial statements are not in agreement with the accounting records and returns; or

• certain disclosures of directors' remuneration specified by law are not made; or

• we have not received all the information and explanations we require for our audit.

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

The objectives of our audit in respect of fraud, are; to identify and assess the risks of material misstatement of the financial statements due to fraud; to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud, through designing and implementing appropriate responses to those assessed risks; and to respond appropriately to instances of fraud or suspected fraud identified during the audit. However, the primary responsibility for the prevention and detection of fraud rests with both management and those charged with governance of the company.

Based on our understanding of the company and its operating environment, we determined that the most significant frameworks which have a direct impact on the preparation of the financial statements are those related to the reporting framework (FRS 102 and the Companies Act 2006) and the relevant tax compliance regulations.

Other laws and regulations which may have a material effect on the financial statements were identified as employment law, health and safety and environmental regulations. Our required procedures in this area are limited to inquiry of Directors and other management, and inspection of any regulatory or legal correspondence. These limited procedures did not identify any actual or suspected non-compliance.

We assessed the susceptibility of the company's financial statements to material misstatement, including how fraud might occur, including evaluating management's incentives and opportunities to manage earnings or influence the reported results. From the results of our assessment, we determined that the principal risk of fraud related to posting inappropriate journal entries. In common with all audits under ISAs (UK), we are required to perform specific procedures to respond to the risk of management override.

As part of an audit in accordance with ISAs (UK) we exercise professional judgement and maintain professional scepticism throughout the audit. Audit procedures performed by the engagement team included:

• We obtained an understanding of the company's internal control systems in order to design audit procedures that are appropriate in the circumstances, but not for the purposes of expressing an opinion on the effectiveness of the company's internal control.

• We obtained an understanding of how the company complies with relevant laws and regulations, by making enquiries of management and those charged with governance.

• Enquiry of management, those charged with governance and the entity’s solicitors around actual and potential litigation and claims.

• Enquiry of entity staff to identify any instances of non-compliance with laws and regulations.

• Performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud

• Reviewing minutes of management and directors meetings

• Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations.

• We test the completeness of sales to address the risk of fraud in revenue recognition.

• Auditing the risk of management override of controls, including through testing journal entries and other adjustments for appropriateness, and evaluating the business rationale of significant transactions that are unusual or outside the normal course of business.

We communicated relevant laws and regulations and potential fraud risks to all engagement team members, and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

There are inherent limitations in the audit procedures described above and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment through collusion, forgery, intentional omissions, misrepresentations or the override of internal control.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's member in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's member those matters we are required to state to the member in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's member, for our audit work, for this report, or for the opinions we have formed.

The statement of comprehensive income has been prepared on the basis that all operations are continuing operations.

The notes on pages 14 to 26 form part of these financial statements.

The notes on pages 14 to 26 form part of these financial statements.

The notes on pages 14 to 26 form part of these financial statements.

Brooklands Healthcare Limited is a private company limited by shares incorporated in Northern Ireland. The registered office is 58 Moneymore Road, Magherafelt, County Londonderry, BT45 6HG.

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

• Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;

• Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues: Interest income/expense and net gains/losses for financial instruments not measured at fair value; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;

• Section 26 ‘Share based Payment’: Share-based payment expense charged to profit or loss, reconciliation of opening and closing number and weighted average exercise price of share options, how the fair value of options granted was measured, measurement and carrying amount of liabilities for cash-settled share-based payments, explanation of modifications to arrangements;

• Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.

The financial statements of the company are consolidated in the financial statements of Conway Holdings No.2 Limited. These consolidated financial statements are available from Companies House website.

The company has taken advantage of the exemption under section 400 of the Companies Act 2006 not to prepare consolidated accounts. The financial statements present information about the company as an individual entity and not about its group.

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business.

Revenue is recognised to the extent that the company obtains the right to consideration in exchange for its care home services, the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is ten years.

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Stocks are stated at the lower of cost and net realisable value.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

The tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

An analysis of the company's turnover is as follows:

Revenue is wholly attributable to activities carried out in Northern Ireland.

The average monthly number of persons (including directors) employed by the company during the year was:

Their aggregate remuneration comprised:

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

The tax effect of the prior year revenue adjustment has been reflected in the current year corporation tax computation and is included as a reconciling item in the current year tax reconciliation, as the prior year corporation tax return will not be amended.

As part of the group restructuring effective 27 August 2025, Brooklands Healthcare Limited, a subsidiary of Conway Holdings No.2 Ltd at the year end, paid dividends in the amount of £45m to its parent company at that time, P J Conway Contractors Limited.

Tangible fixed assets includes assets held under finance leases or hire purchase contracts, as follows:

Freehold land and buildings with a carrying amount of £13,415,714 (2024 - £11,861,347) have been pledged to secure borrowings of the company.

Details of the company's subsidiaries at 31 December 2025 are as follows:

Freehold land and buildings with a carrying amount of £8,447,652 (2024 - £8,514,224) have been pledged to secure borrowings of the company.

Finance lease payments represent rentals payable by the company for certain items of motor vehicles. Leases include purchase options at the end of the lease period, and no restrictions are placed on the use of the assets. The average lease term is 4 years. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments.

Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:

The net deferred tax liability expected to reverse in 12 months is £6,790. This primarily relates to the reversal of tax timing differences on capital allowances.

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

The company has one class of ordinary shares which carry full voting rights, entitles the holders to full rights to participate in dividends as voted and entitles holders to full rights to participate in a distribution.

The company has given an intercompany cross guarantee in favour of PJ Conway Contractors Limited and Conway Estates Limited.

During the year the company entered into the following transactions with related parties:

The following amounts were outstanding at the reporting end date:

During the year, the company acquired land for development from a related party entity under the control of the directors at a value of £600,000. An amount of £600,000 remained outstanding at the reporting date and is included within Other Creditors.

The company has taken advantage of the exemption not to disclose related party transactions with other members of the group under S33.1A of FRS 102, as it is a wholly owned subsidiary.

From 1 January 2025 until 26 August 2025, the immediate parent company of Brooklands Healthcare Limited was P J Conway Contractors Limited, and its registered office is is 58 Moneymore Road, Magherafelt, BT45 6HG.

The Conway Group was restructed effective 27 August 2025, therefore from this date and at 31 December 2025, Brooklands Healthcare Limited's immediate and ultimate parent company is Conway Holdings No.2 Limited, and its registered office is 58 Moneymore Road, Magherafelt, BT45 6HG.

There has been no change to the ownership of the group as a result of the restructuring.

During the year, the company identified that income recognised in year ended 31 December 2025 related to the prior year and should have been recognised in the year ended 31 December 2024, together with the associated debtor balance.

The comparative figures have been restated to increase income and debtors for the year ended 31 December 2024 by £408,510, with a corresponding increase in retained earnings.